一个管道化,资源高效的卷积神经网络架构,用于使用大脑sMRI检测和诊断阿尔茨海默病
1School of Electrical Engineering, Vellore Institute of Technology (VIT) Chennai, Tamil Nadu, India.
Frontiers in neuroscience
|October 31, 2025
概括
本研究介绍了一种资源高效的卷积神经网络 (RECNN),用于使用MRI扫描进行早期阿尔茨海默氏病 (AD) 检测. RECNN框架提供了一种计算效率高,准确的方法来诊断AD,区分轻度和高级阶段.
科学领域:
- 医学成像和人工智能 医学成像和人工智能
- 神经系统疾病 诊断 诊断 诊断
- 医疗保健中的机器学习
背景情况:
- 阿尔茨海默病 (AD) 是一种进展性神经系统疾病,影响老年人的记忆和认知能力.
- 早期发现AD对于减缓疾病进展和及时治疗至关重要.
- 传统的AD诊断方法是计算密集和耗时的,需要高效的自动化解决方案.
研究的目的:
- 引入一个资源高效的卷积神经网络 (RECNN),用于自动检测和诊断阿尔茨海默病.
- 开发一个计算高效的框架来分析AD的脑MRI图像.
- 提高AD诊断方法的准确性和降低传统AD诊断方法的复杂性.
主要方法:
- 实施一个资源高效的卷积神经网络 (RECNN) 框架,利用大脑MRI图像.
- 整合Gabor转换以增强空间频率特征和数据增强以增加样本多样性.
- 应用异常像素分割算法,将受影响的像素分类为轻度或高级AD阶段.
主要成果:
- 与传统方法相比,基于RECNN的系统在AD检测和分类方面表现优异.
- 在诊断阿尔茨海默病方面实现了更高的准确性和稳定性.
- 细分结果有效地区分了轻度和高级AD病例,证实了计算复杂性降低和高诊断可靠性.
结论:
- 该RECNN框架提供了一个资源高效,准确和可扩展的工具,用于使用MRI数据早期检测阿尔茨海默病.
- 加博转换,数据增强和高级细分的结合提供了一个临床适用的解决方案.
- 未来的研究将专注于用更大的数据集验证模型,并探索混合架构以提高诊断性能.
相关概念视频
Magnetic Resonance Imaging
Magnetic resonance imaging (MRI) is a noninvasive medical imaging technique based on a phenomenon of nuclear physics discovered in the 1930s, in which matter exposed to magnetic fields and radio waves was found to emit radio signals. In 1970, a physician and researcher named Raymond Damadian noticed that malignant (cancerous) tissue gave off different signals than normal body tissue. He applied for a patent for the first MRI scanning device in clinical use by the early 1980s. The early MRI...
Brain Imaging
Brain imaging technologies provide critical insights into both the structure and function of the human brain, enabling medical professionals and researchers to diagnose, study, and treat neurological disorders or psychiatric disorders more effectively.
These technologies include computerized axial tomography (CAT or CT scans), positron-emission tomography (PET scans), magnetic resonance imaging (MRI), functional magnetic resonance imaging (fMRI), and Transcranial Magnetic Stimulation (TMS).
These technologies include computerized axial tomography (CAT or CT scans), positron-emission tomography (PET scans), magnetic resonance imaging (MRI), functional magnetic resonance imaging (fMRI), and Transcranial Magnetic Stimulation (TMS).


